How Realistic Are Robotaxis at Tesla in 2020?
Elon Musk's extraordinary efforts require adequate scrutiny.
Wall Street Cuts Targets as Tesla Stock's Bear Case Builds
Sixteen analysts have cut price targets in the past month, with a smattering of analysts downgrading the stock as well.
Apple Stock Dealt a Double Whammy After SCOTUS Upholds App Antitrust Suit
Apple's antitrust defense is moot after a narrow court decision on Monday morning.
The Race to Full Self-Driving Is the Real Finish Line for Uber
Uber's IPO move could be a blip on the road to autonomous driving.
'Amazon of Africa' Is More Like a Nigerian Prince Scam, Says This Shortseller
Shortseller Andrew Left says Jumia's post IPO stock jump is built on fraud.
Allergan Stock Slips Despite Beat and Raised Guidance
Shares of the maker of Botox are struggling despite its latest results exceeding expectations.
A Review of the Regulatory Hurdles Remaining for the CVS Aetna Acquisition
Aetna's additive effects on CVS's earnings might be front and center, but it isn't fully actualized just yet.
CVS Stock Surges as Aetna Acquisition Comes Into View
CVS is setting up an anticipated new stock trajectory for investors.
Is Elon Musk Mortgaging Tesla Shares Against a Potential Margin Call?
Short-sellers are pointing to a big risk for Tesla investors and an opportunity for traders.
An Analysis of the Alphabet-Oracle Dispute as Investors Await DOJ Decision
Alphabet is awaiting word today on whether the U.S. Supreme Court will hear its appeal of a $9 billion copyright lawsuit filed by tech rival Oracle Corp.